Australia Artesunate Market Size & Outlook, 2026-2034


Australia Artesunate Market Insights

  • Based on Reed Intelligence findings, the Australia Artesunate Market reached USD 4.04 Million in 2025 and is estimated to attain USD 7.18 Million by 2034.
  • From 2026 to 2034, the Australia market is expected to grow at a steady CAGR of 6.6%.
  • Within the Formulation category, Injectable Artesunate dominated in 2025 in terms of market size contribution.
  • Over the forecast period, Injectable Artesunate is forecasted to deliver the fastest growth, positioning it as the most lucrative Formulation segment.

Other Key Findings


  • Australia accounted for 0.78% of the global Artesunate Market size in 2025.
  • By 2034, United States is expected to remain the top global market in terms of size.
  • Within Asia Pacific, China is forecasted to dominate the regional Artesunate Market size by 2034.
  • China will be the fastest-growing market in Asia Pacific, projected to achieve USD 62.29 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 4.04 Million
Market Size In 2034 USD 7.18 Million
Largest segment Injectable Artesunate
Units Revenue in USD Million
CAGR 6.6% (2026-2034)
Segmnetation Covered
Formulation
  1. Injectable Artesunate
  2. Oral Artesunate
Application
  1. Severe Malaria Treatment
  2. Uncomplicated Malaria Treatment
End-Use
  1. Hospitals
  2. Clinics
  3. Retail Pharmacies
Distribution Channel
  1. Government Supply Programs
  2. Private Sector Distribution
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends